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Abstract
Eukaryotic transcription factors are grouped into families and, due to their similar DNA binding domains, often have the
potential to bind to the same genomic regions. This can lead to redundancy at the level of DNA binding, and mechanisms
are required to generate specific functional outcomes that enable distinct gene expression programmes to be controlled by
a particular transcription factor. Here we used ChIP–seq to uncover two distinct binding modes for the ETS transcription
factor ELK1. In one mode, other ETS transcription factors can bind regulatory regions in a redundant fashion; in the second,
ELK1 binds in a unique fashion to another set of genomic targets. Each binding mode is associated with different binding
site features and also distinct regulatory outcomes. Furthermore, the type of binding mode also determines the control of
functionally distinct subclasses of genes and hence the phenotypic response elicited. This is demonstrated for the unique
binding mode where a novel role for ELK1 in controlling cell migration is revealed. We have therefore uncovered an
unexpected link between the type of binding mode employed by a transcription factor, the subsequent gene regulatory
mechanisms used, and the functional categories of target genes controlled.
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Introduction
Eukaryotic transcription factors are grouped into families based
on their common DNA binding domains and these families can
extend to dozens of members in mammalian cells. This is typified
by the ETS-domain containing transcription factors, with human
cells encoding 28 different proteins (reviewed in [1]). All these
transcription factors contain very similar DNA-binding domains,
and at least in vitro, their DNA binding specificities are very similar
[2]. It is therefore a challenge to understand how individual family
members can control specific gene expression programmes
without unwanted crosstalk. Such crosstalk would potentially lead
to functional redundancy due to the ability of different family
members to bind to the same sites. Indeed, this has been suggested
by genome-wide interrogation of DNA binding by different ETS
transcription factors, where multiple family members can associate
with the same genomic regions [3–5]. Such functional redundancy
might explain why many of the phenotypes caused by the loss of
ETS proteins are relatively subtle, despite the widespread
expression of these transcription factors (reviewed in [6]).
However, even with this huge potential for functional redundancy,
several mouse knockout studies have revealed specific phenotypes
for individual ETS transcription factors, suggesting that they
function at least partially in a non-redundant fashion. One way for
helping to achieve this specificity of action is through functional
cooperation with other transcription factors. This is illustrated by
the association of ETS1 with RUNX1 [4] and ELK1 with SRF
[5], although in both cases, this co-association is only extended to a
minority of the binding events identified in vivo.
ELK1 together with ELK4/SAP-1 and ELK3/SAP-2/Net,
constitute the ternary complex factor (TCF) subfamily of ETS-
domain transcription factors (reviewed in [7–8]). Like all ETS
proteins, these transcription factors all bind to variants of the
GGAA/T motif embedded in a larger 10 bp consensus sequence in
vitro, and in the case of ELK1, this binding preference is also
recapitulated in vivo [5]. Members of the TCF subfamily can
function in a cooperative manner with SRF, and this is driven in
part through the close juxta-positioning of their DNA binding
sites, but also through direct protein-protein interactions [9–11].
Amongst the TCFs, ELK1 is the best studied and it is directly
activated by phosphorylation in response to activation of the MAP
kinase signalling cascades [reviewed in 7–8]. Mouse knockouts
show minimal phenotypic changes [12], suggesting that there
might be functional redundancy amongst members of this
subfamily. This was recently demonstrated to be the case in the
context of T-cell differentiation, where the loss of ELK1 caused
only subtle effects and there was clear redundancy of function
between ELK1 and ELK4 [13]. This redundancy of function was
demonstrated at both the level of DNA binding and target gene
regulation. Similarly, redundancy at the level of chromatin
binding has been shown to occur in HeLa-S3 cells, where
depletion of ELK1 led to decreased binding to chromatin, and a
concomitant rise in the binding of ELK4 to the same regions in a
subset of targets [14]. Thus, understanding the function of ELK1
and other TCFs is complicated by the compounding factors
associated with functional redundancy in this transcription factor
family. Recently however, a genome-wide RNAi screening study
identified ELK1 as a critical factor in promoting cell survival in
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therefore provide a tractable system for dissecting ELK1 function.
Here, we have combined ChIP-seq and gene expression array
analysis to interrogate the ELK1 target gene network in MCF10A
cells. We demonstrate that ELK1 binds to its target regions in two
distinct ways: uniquely or redundantly with other ETS proteins.
The binding regions associated with these two types of interaction
show different characteristics concerning the frequency and
quality of the ELK1 binding sites and the association with the
binding of heterotypic transcription factors. Unexpectedly, the two
types of binding regions are associated with different modes of
target gene regulation and moreover, this differential regulation
also affects distinct functional categories of target genes. This is
demonstrated for the unique ELK1 binding mode, where this
factor controls cell migration, through acting in a positive manner
to activate a set of functionally related target genes.
Results
Identification of an ELK1-regulated target gene network
Functional redundancy amongst members of multi-gene tran-
scription factor families such as the ETS transcription factors is a
potential problem when attempting to uncover the function of
individual family members (reviewed in [1]). We therefore selected
the human breast epithelia-derived MCF10A cells to dissect the
role of ELK1 in controlling gene transcription, as ELK1 has been
shown to be important for their survival and its deficiency cannot
therefore be fully compensated for by other family members [15].
First, we depleted ELK1 levels in MCF10A cells and measured the
effect this had on the transcriptome. The effect of ELK1 depletion
was assessed in cells grown in the absence of EGF or in cells
treated with EGF for 30 mins to activate ERK MAP kinase
pathway signalling. ELK1 levels were efficiently reduced following
treatment with siRNA (Figure 1A) and ERK activation and ELK1
phosphorylation were rapidly induced by EGF treatment
(Figure 1B). Over 6000 genes consistently changed their expression
(P-value,0.05; Q-value,0.1) following depletion of ELK1 either
in the presence or absence of EGF, and roughly equal numbers of
genes were up- and down-regulated in each case (Figure 1C; Table
S1). In contrast, far fewer genes consistently changed their
expression upon treatment with EGF (Figure S1), suggesting a
more pleiotropic cellular response to ELK1 loss. Importantly, the
majority of genes whose expression changed upon ELK1 depletion
did so irrespective of the activity status of the ERK signalling
pathway as only 10% of siELK1-sensitive genes were uniquely
altered by ELK1 depletion in the presence on EGF, while 73%
were changed both in the presence and absence of EGF
(Figure 1D). This suggests a role for ELK1 in controlling gene
expression which is largely independent from EGF signalling
status.
The large number of gene expression changes elicited in
MCF10A cells by ELK1 depletion suggested that a sizeable
proportion of the changes likely arise as an indirect consequence of
ELK1 loss. Therefore we used ChIP-seq to establish the direct
target genes for ELK1. These studies were performed in MCF10A
cells grown in the absence of EGF, as ELK1 binding to chromatin
is thought to occur irrespective of signalling conditions [16]. A
total of 529 genomic binding regions for ELK1 were identified in
two independent experiments (FDR,10), and denoted as a ‘‘high
confidence’’ dataset (Table S2). By assigning binding regions to the
nearest annotated TSS, 516 target genes were identified. A range
of binding regions were validated by ChIP followed by qPCR and
all the regions tested showed significant enrichment for ELK1
binding compared to a control non-specific antibody (Figure 2A;
Figure S2). We also tested several regions from a lower confidence
dataset where peaks were only identified in one of the two
experiments and although these scored positive in qPCR-based
assays, their relative enrichment levels were generally lower than
observed for the high confidence data set (Figure 2A; Figure S2).
Many of the regions in the high confidence dataset are also bound
by ELK1 in a different human breast cell derived line, MDA-MB-
231 cells (Figure S3A). Moreover, there is a large overlap of ELK1
binding regions with those identified in two previous studies using
ChIP-chip (59%; [5]) and ChIP-seq (43%; [17]) in HeLa cells,
with 106 (33%) regions in common between all three studies
(Figure S4). This suggests that there is a core set of ELK1 binding
regions common to several cell types but also a number of cell
type-specific binding events. ELK1 binding regions in MCF10A
cells are enriched in promoter -proximal regions with 36% within
10 kb upstream from the TSS of the nearest gene (Figure 2B).
Functionally, the ELK1 binding regions were associated with
genes grouped under a number of distinct gene ontology
classifications by analysis using GREAT [18]. Prominent catego-
ries included a number of terms associated with the regulation of
gene expression (e.g. ‘‘ribosomal subunit’’ and ‘‘mediator com-
plex’’) and with the actin cytoskeleton and cell adhesion (Figure
S5). The association of ELK1 with genes encoding the core gene
expression machinery was expected from previous results [5], but
a role in potentially controlling genes involved in cytoskeletal-
mediated events is a novel discovery.
Next, we assigned each ELK1 binding region to the nearest
gene annotated in the RefSeq database, and compared this list
with the ELK1-regulated genes revealed by expression microarray
analysis. Over half of the genes associated with ELK1 binding
regions (273 out of 516 genes) are also deregulated under at least
one of the conditions we tested upon ELK1 depletion (245 were
changed in the absence of EGF and 223 in the presence of EGF).
Roughly equal numbers of ELK1 binding regions are associated
with up- and downregulated genes, irrespective of EGF treatment
(Figure 2C). Importantly, comparison of the ChIP-seq-derived
Author Summary
One of the major outstanding questions in eukaryotic
gene regulation is how transcription factors with seem-
ingly very similar DNA binding specificities elicit specific
biological responses. The ETS transcription factor family
provides a paradigm for investigating this phenomenon.
Here, we have focused on the ETS transcription factor
ELK1, and by combining genome-wide binding analysis
coupled with gene expression analysis we have dissected
two distinct gene regulatory activities for this transcription
factor. In each of these regulatory modes, ELK1 exhibits
distinct DNA binding characteristics which correlate with
either positive or negative transcriptional activities and
give rise to functionally distinct gene expression pro-
grammes. We demonstrate a novel function for ELK1 in
controlling cell migration through one of these regulatory
modes. Thus, we have demonstrated a clear link between
the types of regulatory region bound by a transcription
factor and its ability to control gene expression (i.e. in a
positive or negative manner) and the functional down-
stream consequences of its target gene cohort. This work
has implications for understanding how members of other
multi-protein transcription factor families might function
to generate different downstream functional consequenc-
es through engaging with different types of regulatory
regions.
DNA Binding Modes Determine Transcription Programs
PLoS Genetics | www.plosgenetics.org 2 May 2012 | Volume 8 | Issue 5 | e1002694ELK1 target genes with randomly selected gene sets demonstrated
that the overlaps with the ELK1-regulated gene expression data
are highly significant in all cases (z-scores ranging from 3.65 to
4.99). Further analysis of the results demonstrated that the
majority of the 273 deregulated genes associated with ELK1
binding regions are the same irrespective of whether EGF was
added to the cells or not (Figure 2D). However, amongst genes
which are upregulated by EGF, there are 17 that are bound by
ELK1, and of these, 13 show diminished expression following
ELK1 depletion. This is in keeping with previous findings that
ELK1 is associated with EGF/ERK pathway-mediated target
gene activation but further illustrates that this appears to be a
relatively minor role of ELK1 in this system. Functionally, the
direct ELK1 target genes defined by this analysis retained
categories identified in the entire ChIP-seq data set such as
association with gene expression control and the actin cytoskeleton
but in addition, a new category, apoptosis/cell death, was
identified as being regulated by ELK1 (Figure S6A–S6C).
Together, these results identify a core set of direct ELK1 target
genes, whose regulatory regions are bound by ELK1 and whose
expression is perturbed upon depletion of ELK1. This set of genes
likely represent directly regulated ELK1 target genes which we
subsequently analysed further and are henceforth referred to as
‘‘ELK1 target genes’’.
ELK1 binding regions can be subdivided based on co-
occurring regulatory features
Previous ChIP-chip studies using promoter arrays demonstrated
that ELK1 binding regions fall into three broad categories; regions
that are also bound by SRF, regions that can also be bound by
other ETS transcription factors and regions which are apparently
uniquely bound by ELK1 independently from these other
transcription factors [5,14]. To establish whether we could detect
similar overlaps with ELK1 binding regions on a genome-wide
scale, we compared our ChIP-seq data with published ChIP-seq
data for SRF and other ETS transcription factors. First, to address
the potential for redundant binding of different ETS proteins, we
compared the ELK1 ChIP-seq data with that of a divergent ETS
factor GABPA [19]. A substantial overlap was observed between
ELK1 and GABPA binding regions (43% of ELK1 binding
regions) despite the differences in cell types analysed (Figure 3A).
This overlap in binding suggests potential redundancy of binding
site occupancy by these different ETS factors. We define the group
of regions which can potentially be bound by both ELK1 and the
divergent ETS protein GABPA as ‘‘ELK1 redundantly bound
regions’’, whereas those bound by ELK1 and not GABPA are
termed ‘‘ELK1 uniquely bound regions’’. To establish whether
this subcategorisation held true when other ETS transcription
factors were considered, we compared ChIP-seq data for nine
other ETS transcription factors performed in a variety of cell lines
with ELK1 binding regions which were classified as ‘‘unique’’ and
‘‘redundant’’. With the exception of the highly related subfamily
member ELK4, very little overlap was seen with binding regions in
the ‘‘unique’’ subcategory but in 8/10 cases, there was significantly
more overlap of these other ETS transcription factors with the
‘‘redundant’’ dataset (Figure S7B). Importantly, 67% of the
‘‘unique’’ ELK1 binding regions were not bound by any of the
more divergent ETS proteins in any of these studies, supporting
our subcategorisation of these regions. We also compared our
ChIP-seq data with ChIP-seq data for SRF from Jurkat cells [19].
Again, a substantial overlap was seen between ELK1 and SRF
binding regions despite the different cell types involved (28% of
ELK1 binding regions; P,0.001) (Figure S7C). A comparison of
ELK1 and SRF bound regions with the binding regions for
GABPA permits further subcategorisation of binding events, and
reveals a group of regions which are bound by ELK1 alone in the
absence of potential redundant binding with GABPA or co-
binding with SRF (Figure S7C).
In order to look for potential reasons for the non-identical
transcription factor occupancy, we compared the regions bound
uniquely by ELK1 (termed ‘‘unique’’) and those which can also be
bound by GABPA (termed ‘‘redundant’’). First, we examined their
location relative to the nearest TSS. The ‘‘unique’’ regions showed
Figure 1. Depletion of ELK1 affects gene expression. Western blots of (A) ELK1 and ERK2 levels in MCF10A cells starved for EGF and treated
with siGAPDH or siELK1 and (B) ELK1 and ERK2 phosphorylation levels in MCF10A cells following EGF treatment for the indicated times. Arrows
indicate slower migrating phosphorylated ELK1 species. (C) Summary of microarray analysis of gene expression changes caused by ELK1 depletion in
either EGF-starved or EGF-stimulated cells. The numbers of genes which become up- or down-regulated upon ELK1 depletion are indicated. (D)
Overlap between genes which show a siELK1-induced change in mRNA levels at 0 min and 30 min of EGF stimulation.
doi:10.1371/journal.pgen.1002694.g001
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the TSS, whereas 93% of the ‘‘redundant’’ regions were located in
this region and these were largely tightly centered around the TSS
(Figure 3B). Next, we implemented a de novo search for over-
represented DNA motifs within the binding regions. Three
prominent motifs were identified in the ‘‘unique’’ dataset
corresponding to ETS, SRF and AP1 binding sites, whereas the
‘‘redundant’’ dataset revealed only a motif corresponding to an
ETS transcription factor binding site (Figure 3C). Similar results
were obtained when using position weight matrices for all known
human transcription factor binding motifs listed in the JASPAR
and TRANSFAC databases to search for over-represented motifs
in these two datasets (data not shown). The ETS motifs identified
in the ELK1 binding peaks closely resembled the motifs identified
in a recent high throughput in vitro binding site selection study [2]
(Figure S8) and what was identified in a ChIP-chip study for ELK1
performed in HeLa cells [5], although differences in nucleotide
preferences at several positions can be observed, generally being
more stringent in vitro. Further inspection of the ELK1 binding
regions demonstrated that the frequency of the three hexamers
comprising the core CCGGAAGT binding motif was much higher
in the ‘‘redundant’’ (763 sites in 226 regions) than in the ‘‘unique’’
dataset (403 sites in 303 regions). This also suggests that more than
one binding event might be associated with ‘‘redundant’’ regions.
Indeed, the number of motifs per region corresponding to
hexameric derivatives of CCGGAAGT is significantly higher in
the ‘‘redundantly’’ bound regions (commonly three sites per
region) than in the ‘‘unique’’ regions (generally only one site per
region) (Figure 3D). We investigated whether there were any
particular spatial constraints among the multiple ETS sites found
in the ‘‘redundant’’ regions but there was nothing obvious
detected. In contrast to the differences seen when considering
the core CCGGAAGT binding motif, the occurrence of
hexameric derivatives of the variant ETS binding motif CAG-
GATGT is virtually identical in the two datasets (Figure 3D).
However, some unique regions have only this relaxed variant,
whereas all redundant regions have at least one ‘‘strong’’
consensus site. This suggests that the binding specificity is
generally more divergent from the core consensus when unique
binding of ELK1 is observed. Part of the reason for the relaxed
binding specificity likely relates to the presence of co-occurring
SRF binding motifs which are present in 54% of ‘‘unique’’ regions
Figure 2. Identification of directly regulated ELK1 target genes. (A) Summary of ChIP-seq data validation (see Figure S2). Box plots show the
median (horizontal lines) and the distribution of the enrichment levels, in qPCR validation of ELK1 or IgG ChIP samples. Binding regions were
randomly selected from the high or low confidence ChIP-seq datasets. As a comparison, the values from regions which do not detectably bind ELK1
are shown (Neg). Data are from three biological repeats. (B) Genomic distribution of ELK1 ChIP-seq regions from the high confidence dataset (left)
compared to a random distribution (right). Sectors corresponding to the promoter (up to 10 kb upstream from the TSS), the downstream region (up
to 10 kb downstream from the TTS) and the UTRs are indicated. (C) Overlap between genes assigned to ELK1 ChIP-seq regions and genes which show
a change in mRNA levels upon ELK1 depletion under the indicated conditions of EGF stimulation. Z-scores were obtained by comparing with an
overlap of the ChIP-seq gene list with 10,000 random lists containing the same numbers of genes. (D) Overlap between numbers of genes which are
associated with ELK1 binding events and show a siELK1-induced change in mRNA levels at 0 min and 30 min of EGF stimulation.
doi:10.1371/journal.pgen.1002694.g002
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greater number (P-value,1610
26) of SRF motifs appear to form
‘‘modules’’ with adjacent ETS motifs in the ‘‘unique’’ dataset,
where the two motifs co-occur within a 50 bp window (Figure 3E).
It is possible that co-binding of factors to AP1 binding motifs also
influences the binding specificity and functionality of ELK1, as the
frequency of FOS binding to the same regions in a different ChIP-
seq study [20] is significantly higher with the ‘‘unique’’ binding
regions (Figure 3F). Interestingly, there are significantly more
overlaps between ELK1 binding and FOS binding in regions
associated with genes activated by ELK1 (27/141) rather than in
genes where ELK1 acts in a negative manner (13/137) (P-
value=0.021), which is suggestive of a role for AP1 in enhancing
the activity of ELK1. In keeping with a potential role for AP1 in
modulating ELK1 function, the frequency of occurrence of AP1
binding motifs is also significantly higher in the ‘‘unique’’ binding
regions (Figure S7D). Indeed, we can detect binding of the AP1
component FOS to several of the ‘‘unique’’ ELK1 binding regions
(Figure S7F).
Together, these results therefore identify two major types of
ELK1 binding regions which can be independently characterized
by their locations, the types and numbers of DNA binding motifs
Figure 3. ELK1 binding region characterisation. (A) Overlap between regions bound by ELK1 (MCF10A cells) and GABPA (Jurkat cells; [17]). (B)
Distribution of distances between peak summits and the nearest TSS for regions bound uniquely by ELK1 (‘‘unique’’-top) or redundantly with GABPA
(‘‘redundant’’ -bottom)(limited to within 2 kb up- or downstream). (C) TFBS logos obtained through STAMP-assisted visualisation of Weeder-derived
position weight matrices of motifs overrepresented in ‘‘unique’’ (top) and ‘‘redundant’’ (bottom) ELK1-bound regions. Only the logos most closely
resembling transcription factor binding sites present in the JASPAR database are shown. The second and third logos shown for the ‘‘unique’’ regions
were identified by sequentially masking out the ETS and SRF binding motifs respectively. (D) Distributions of the number of ETS motifs found in the
‘‘unique’’ and ‘‘redundant’’ ELK1-bound regions. Occurrences of non-overlapping unique hexamers, corresponding to exact matches to derivatives of
the octameric motifs shown above the graphs were counted. ‘‘Background’’ represents the distribution of an inverted ETS motif. (E) Occurrence of an
ETS-SRF module in ‘‘unique’’ and ‘‘redundant’’ ELK1-bound regions. A module is defined as containing an ETS and SRF site within 100 bp of the ELK1
peak summit and a distance between the ETS and SRF motifs of less than 50 bp. (F) Overlap between the indicated categories of regions bound by
ELK1 in MCF10A cells and regions bound by FOS in HeLa-S3 cells [18].
doi:10.1371/journal.pgen.1002694.g003
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PLoS Genetics | www.plosgenetics.org 5 May 2012 | Volume 8 | Issue 5 | e1002694Figure 4. ‘‘Unique’’ and ‘‘redundant’’ ELK1-bound regions regulate distinct sets of target genes. (A) K-means clustering of expression
levels of genes associated with ELK1-bound regions that show a significant response to siELK1 and/or EGF treatment. Individual clusters (1–8) are
separated by dotted lines. (B) Summary profiles of the target genes in clusters 2, 4, 7 and 8. The data are presented as changes of individual (grey) and
average (black) expression values of genes in each cluster under each of the four experimental conditions. For each gene, the mean of the signals
across all four conditions was set as zero, and expression levels (z-transformed) presented are relative to this value. (C) Distribution of ‘‘unique’’ and
‘‘redundant’’ region-associated ELK1 target genes in the clusters identified in (A), with Chi square or Fisher Exact test-derived P-values. (D) Distribution
of genes up- and down-regulated by ELK1 depletion in the ‘‘unique’’ (U) and ‘‘redundant’’ (R) ELK1 target gene datasets after 0 or 30 mins EGF
stimulation. (E) Heatmap summary of changes in expression of three genes from the ‘‘redundant’’ ELK1 target dataset upon treatment with siELK1
(from microarrays) or siGABPA (by RT-PCR) (relative to a siGAPDH-transfected control), at 0 and 30 minutes of EGF stimulation. (F) Enrichment of the
indicated GO categories in expression clusters identified in (A); P-values were obtained in a Chi-square test and refer to the cumulative enrichment of
clusters which cross the dashed line vs. those that do not. (G) Heatmap of the distribution of GO terms identified for ‘‘unique’’ and ‘‘redundant’’ ELK1-
associated genes. Each GO term is scored by 2log10(P-value). Lines on the left mark terms related to gene expression (grey), actin/migration (green)
and cell survival (red).
doi:10.1371/journal.pgen.1002694.g004
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compete for binding to these sites. Regions which are uniquely
bound by ELK1 tend to contain fewer and/or weak ETS binding
motifs and are often bound by other partner transcription factors
such as SRF and AP1, whereas those redundantly bound by
different ETS factors more often contain multiple strong ETS
binding motifs, and there is little evidence for the occurrence of
common co-binding transcription factors.
Different ELK1 binding modes are associated with
distinct categories of target genes
Having defined two different types of ELK1 binding regions, we
next wished to investigate whether these regions are associated
either with different gene regulatory mechanisms, and/or with
controlling different cellular processes. First, we used unsupervised
k-means cluster analysis to provide an unbiased way to identify
groups of genes which responded differently to ELK1 depletion in
the presence and absence of concurrent treatment with EGF.
Here, we focussed only on the 273 direct target genes identified as
being associated with regions bound by ELK1 in the ChIP-seq
analysis. Data are depicted relative to average expression of each
gene across all conditions to enable common regulatory patterns to
be discerned. Eight gene expression clusters were identified which
show distinct patterns of responses to these different treatments
(Figure 4A, 4B; Figure S9; Table S3). We then examined whether
the ‘‘unique’’ or ‘‘redundant’’ ELK1 target genes were associated
with any particular cluster(s). Interestingly, we found a clear
separation of target gene response associated with different ELK1
binding modes. Clusters 2 and 4 were significantly enriched for
‘‘unique’’ binding whereas clusters 7 and 8 were enriched for
‘‘redundant’’ binding (Figure 4C). Cluster 2 contains genes which
are upregulated by EGF treatment but show an attenuated
response upon ELK1 depletion, whereas genes in cluster 4 are
largely unaffected by EGF but downregulated following ELK1
depletion (Figure 4A and 4B). In contrast, the genes in clusters 7
and 8 are largely non-responsive to EGF treatment but their
expression is enhanced upon ELK1 depletion (Figure 4A and 4B).
In total, over 75% (205) of the ELK1 target genes are found within
the clusters which are strongly correlated with either ‘‘unique’’ or
‘‘redundant’’ binding. We analysed this further by comparing the
response of genes bound either by ELK1 alone (‘‘unique’’) or by
ELK1 and GABPA (‘‘redundant’’) (see Figure 3A) to ELK1
depletion. Here, a significant shift in the regulatory mode could
clearly be seen, with ‘‘uniquely’’ bound genes being largely
downregulated while ‘‘redundantly’’ bound genes were upregu-
lated following ELK1 loss (Figure 4D). Mechanistically, one likely
mode of regulation of the latter class of genes, is that ELK1
normally acts repressively at these genes and upon depletion is
replaced by a different transcription factor such as GABPA which
can potentially provide stronger gene activation. To provide data
supporting this prediction, we compared cells depleted of either
ELK1 or GABPA and examined the response of three genes
predicted to be redundantly bound by ELK1 and GABPA. The
expression of all three genes increased upon depletion of ELK1.
However, the reciprocal occurred upon depletion of GABPA and
decreased expression of all three genes was observed (Figure 4E).
Thus, ELK1 and GABPA work antagonistically in controlling
gene expression and this is particularly evident in clusters 7 and 8
for targets such as SCNM1 and MDM4. Overall, these results
indicate that the regulatory mode attributed to ELK1 strongly
correlates with the type of ELK1 binding mode adopted on the
target genes.
Next, we wanted to examine whether the type of binding and
regulation adopted by ELK1 might also relate to functionally
distinct outcomes in terms of the cohorts of genes regulated. We
therefore examined whether any of the enriched GO term
categories for the direct ELK1 target genes are preferentially
associated with any of the different expression clusters. Impor-
tantly, we found that genes from particular functional categories
are not evenly spread throughout the clusters (Figure 4F). Instead,
genes forming the category ‘‘cytoskeleton and migration’’ are
enriched in clusters 2, 4, 5 and 6, while genes within the ‘‘cell
survival’’-related terms are enriched in clusters 2 and 6. As one
common defining feature of clusters 2, 4, 5 and 6 is downregu-
lation following ELK1 depletion, these data suggest a positive role
for ELK1 in driving transcription of genes in these functional
categories. Therefore the gene expression clusters associated with
particular ELK1 binding and regulatory modes are associated with
distinct functional categories of genes. This suggests that the two
types of ELK1 binding regions might regulate the expression of
genes encoding proteins involved in distinct cellular processes and
ultimately lead to distinct functional outcomes. To examine
whether this is the case, we separated the direct ELK1 target gene
dataset into ‘‘unique’’ and ‘‘redundant’’ groups according to the
type of ELK1 binding mode, and screened these datasets for
different functional categories of genes using DAVID [21]. We
then ranked the resulting enriched GO terms according to
statistical significance and saw a clear separation of these GO
terms, according to association with either ‘‘unique’’ or ‘‘redun-
dant’’ ELK1 binding with only minimal overlap (Figure 4G; Table
S4). Genes ‘‘uniquely’’ bound by ELK1 were generally associated
with terms related to the actin cytoskeleton (e.g. actin binding,
focal adhesions etc.), whereas ‘‘redundantly’’ bound genes were
generally associated with gene expression control (e.g. RNA
processing, translation etc.). Some GO term categories related to
gene expression were also associated with genes assigned to
‘‘uniquely’’ bound ELK1 regions but these strongly differed from
the categories associated with genes assigned to ‘‘redundantly’’
bound regions, demonstrating a further separation of binding
mode with respect to the types of genes regulated. Interestingly,
terms related to cell survival were generally associated with genes
assigned to ‘‘uniquely’’ bound ELK1 regions but also appeared in
the ‘‘redundantly’’ bound dataset, albeit with lower significance.
These results therefore reveal an unexpected link between the
mode of ELK1 binding to the regulatory region of a gene, the type
of regulation of the associated genes and the functional classifi-
cations of the target genes controlled. In particular, genes
associated with the cytoskeleton and migration, tend to be
regulated in a positive manner by ELK1, and also are apparently
bound specifically by ELK1 as they are not targets for potential
redundant binding by alternative ETS transcription factors like
GABPA.
ELK1 controls cell migration
The above results indicate that a key role for ELK1 is mediated
through its ‘‘unique’’ binding mode where it controls the activity of
genes associated with the actin cytoskeleton and cell migration. To
explore the functional significance of this association, we created
networks of proteins encoded by ‘‘unique’’ and ‘‘redundant’’
ELK1 target genes using coexpression, textmining, knowledge and
experimental data as proximity criteria to identify interconnectiv-
ities. These networks were screened for enrichment in GO terms
centred on specific cellular functions. The genes associated with
‘‘migration/cytoskeleton’’ formed a prominent subnetwork within
the ‘‘unique’’ dataset; more interestingly, a large number of the
genes which form the core of this subnetwork were shown by
microarray analysis to be misregulated following ELK1 depletion
(Figure 5A and Figure S11). The role of ELK1 in controlling key
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target genes were selected from the GO term category ‘‘migra-
tion/cytoskeleton’’, whose regulatory regions are bound by ELK1.
The majority of these showed decreases in expression upon ELK1
depletion from MCF10A cells in the absence and/or presence of
EGF (Figure 5B, and Figure S10A). The majority of these
decreases in ELK1 target gene expression were also observed in
MDA-MB-231 cells (Figure S3B). Importantly, depletion of
GABPA did not cause any significant changes in expression of
these genes, in keeping with our designation of these genes as
‘‘unique’’ targets for ELK1 (Figure S10B). SRF has also been
associated with controlling genes involved in the actin cytoskeleton
and cell migration [22,23]. We therefore also assessed the role of
SRF in regulating the same group of genes. The expression of
three genes was significantly reduced upon siRNA depletion
(Figure S10C). Two of these, CTGF and ACTB, are also positively
regulated by ELK1. Thus ELK1 and SRF appear to have both
distinct and common targets amongst the ‘‘migration/cytoskele-
ton’’ gene network.
A second subnetwork of ‘‘cell survival’’ was also identified which
is comprised of genes associated with the ‘‘unique’’ ELK1 dataset
(Figure S12), but for the ‘‘gene expression’’ category, two different
types of network could be observed (Figure S13A and S13B). In
the latter case, again a subnetwork could be identified which is
controlled through the ‘‘unique’’ binding of ELK1 and which
features clusters of genes encoding signal-responsive transcription
factors including immediate-early gene products and several
nuclear hormone receptors. In contrast, an additional subnetwork
was revealed which is apparently rather controlled through regions
that can be redundantly bound by ELK1 and other ETS factors
such as GABPA, and is mainly made up of genes encoding
ribosomal subunits and mediator components. These findings
support the association of different ELK1 binding modes with
different functional categories of target genes, but also highlight
the importance of ELK1 in controlling key nodes in the networks.
Our results predict that the loss of ELK1 should have profound
consequences for the cellular phenotype due to the collapse of the
networks involved with controlling the relevant cellular functions,
especially in processes associated with the cytoskeleton and
downstream effects such as cell migration. To test this, we first
investigated the status of the cytoskeleton following ELK1
depletion in MCF10A cells. Following ELK1 depletion, cells
became less spread and exhibited altered cytoskeletal character-
istics, including a loss of membrane protrusions and enhanced
levels of subcortical actin (Figure 6A and 6B). The loss of
membrane protrusions suggested that the cells might lose their
migratory properties. To test this, we used wound healing assays,
and upon ELK1 depletion wound closure was greatly attenuated
(Figure 6C and 6D). ELK1 depletion also led to reductions in cell
numbers (Figure S14) which could at least in part contribute to the
reductions in wound closure efficiency. We therefore used single
cell tracking to examine the movement of individual cells
associated with cell clusters. Fewer cells detached from these
clusters in the siELK1-transfected population (Figure 6E) and
those cells which did detach showed greatly impaired migration
(Figure 6F). Many of the same phenotypic features could be
observed upon ELK1 depletion in MDA-MB-231 cells (Figure
S3C–S3E).
These results confirm that ELK1-mediated regulation of a
target gene network associated with the actin cytoskeleton and cell
migration correlates with the expected phenotypic consequences.
To confirm that the key ELK1 target genes in this network play a
role in controlling cytoskeletal-related activities such as cell
migration, we individually depleted nine of these genes (Figure
S15A) and analysed the resulting cellular phenotypes. Defects in
the actin cytoskeleton (Figure S15B and S15C) and reduced
wound healing (Figure S15D and S15E) were observed in several
cases. Importantly, cell migration was defective in the majority of
cases (Figure 6G and Figure S16), clearly demonstrating that the
ELK1 target genes play a role in controlling this process.
Discussion
Genome-wide studies are beginning to reveal the target genes
for many transcription factors and one of the unanswered
questions is how specific responses are generated by a particular
transcription factor, especially in the presence of other proteins
from the same family that can potentially bind the same sites. Here
we have investigated the ETS family transcription factor ELK1
and made the unexpected discovery, that the types of binding
mode exhibited by ELK1, correlate not only with the regulatory
outcomes at the associated target genes but lead to the control of
distinct networks of genes with defined cellular functions.
Figure 5. ELK1 controls a network of actin/migration-related
genes. (A) Network formed by proteins encoded by actin cytoskeleton/
migration-related genes associated with ‘‘unique’’ ELK1-bound regions
(each protein denoted by a circle). Asterisks mark genes tested in (B)
(PFN1 is associated with a redundant region). Grey circles indicate that
gene expression is changed upon ELK1 depletion. See Figure S11 for
details of gene names. (B) mRNA levels of nine actin cytoskeleton- and
migration-associated genes were measured by RT-qPCR in serum
starved MCF10A cells transfected with siELK1 and normalised to an
siGAPDH-transfected control; bars show average values from three
biological repeats with standard deviations. Levels of ELK1 mRNA
indicate the efficiency of depletion; RBL2, EFR3A are negative controls
which do not associate with ELK1. * P,0.05, ** P,0.01 (Student’s paired
t-test).
doi:10.1371/journal.pgen.1002694.g005
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functionally classified according to their mode of ELK1 binding
and this in turn controls their mode of regulation. Inspection of
ELK1 binding regions demonstrates that these can be divided into
at least three distinct categories based on the binding of other
transcription factors; co-binding with a different transcription
factor SRF, competition with GABPA (and potentially other ETS
proteins) and binding in a distinct manner independently from
these. To simplify our analysis, and concentrate on the potential
interplay with other ETS transcription factor family members, we
focused on two modes of ELK1 binding; regions which can be
occupied by GABPA and ELK1 (‘‘redundant’’ regions) or regions
that can be occupied by ELK1 and apparently not GABPA
(‘‘unique regions’’). While further analysis of the redundant and
unique regions for binding by other ETS proteins from other
ChIP-seq studies broadly supports this classification, it is important
Figure 6. Depletion of ELK1 affects the cytoskeleton and the motility of MCF10A cells. (A) Control and ELK1-depleted MCF10A cells were
starved for EGF for 48 h, subsequently stimulated with EGF for 24 hours and stained with phalloidin to visualise the actin cytoskeleton. Nuclei are
stained with Hoechst (blue). Red arrows – subcortical actin, white arrowheads – membrane protrusions. (B) Quantification of the percentage of cells
exhibiting membrane protrusions from siGAPDH- and siELK1-transfected cells. Bars show average values from three biological repeats with standard
deviations; three fields were scored for each repeat. (C) Representative images of wounds created in monolayers of siGAPDH- or siELK1-transfected
MCF10A cells, at t=1 h and t=15 h post-stimulation with EGF. Lines show borders of areas which were used for quantification. (D) Areas of wounds
in monolayers of MCF10A cell treated as in (C) were measured at one-hour intervals of live imaging experiments; data are shown for the siELK1-
treated population as a percentage increase of area compared to control siGAPDH treated cells. Graph shows average of three biological repeats with
standard deviation. (E) Quantification of MCF10A cells which detached from clusters in the siGAPDH and siELK1-treated populations between
t=60 min and t=460 min after EGF treatment. The experiment was performed in three biological repeats and in each case the fate of 20 cells was
determined. (F) Migratory trajectories of MCF10A cells transfected with siGAPDH or siELK1, manually tracked between t=1 h and t=7 h of EGF
stimulation. Each coloured line represents the path travelled by an individual cell. (G) Box plots of the distributions of trajectory lengths for MCF10A
cells transfected with the indicated siRNA species, manually tracked between t=1 h and t=7 h after EGF stimulation. The experiment was performed
in 3 biological repeats, in each case 10 cells were tracked. The grey shaded area corresponds to the second and third quartiles of the migratory range
covered in control (GAPDH siRNA transfected) cells. Statistical significance was determined in Student’s paired t-tests (B and F) or P-values were
obtained from Kolomogorov-Smirnov tests (E and G). * P,0.05 ** P,0.01 *** P,0.005.
doi:10.1371/journal.pgen.1002694.g006
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apparently ‘‘unique’’ regions cannot be bound by another ETS
factor under different conditions or in another cell type.
Nevertheless, this classification enabled us to ultimately define an
important role for ELK1 in controlling cell behaviour where it acts
through genes associated with the ‘‘unique’’ regions. These two
types of binding regions showed distinct characteristics. ‘‘Redun-
dant’’ regions are generally centered on the TSS and at the
sequence motif level, contain multiple sites which closely match
the generic consensus ETS protein binding motif CCGGAAGT.
Moreover, there is little evidence for the occurrence of common
co-binding transcription factors. In contrast, the ‘‘unique’’ regions
are located in a wide distribution around the TSS and generally
show a relaxed match to the ETS binding motif. Furthermore,
these regions contain fewer ETS-like binding motifs than the
‘‘redundant’’ regions. The ‘‘unique’’ regions also show motif
enrichment and binding of other classes of transcription factors;
AP1 and SRF. The association between ELK1 and SRF has been
well established previously (reviewed in [5,24]) but the association
with AP1 is a novel finding. This AP1 connection is related to early
studies on the ELK1-regulated FOS promoter which suggested
feedback inhibition by FOS [25]. Furthermore, recent genome-
wide ChIP-seq studies demonstrate that the ETS proteins ERG,
ETV1, and ETV4 exhibit strong co-binding with AP1 in prostate-
derived cells whereas others (ETS1 and GABPA) do not [26].
Thus, co-association with AP1 appears to be a common mode of
action for a subset of ETS transcription factors, including ELK1.
Several other features of ELK1 binding have previously been
reported from genome-wide binding analyses for other ETS
transcription factors. For example, as observed for ELK1, ETS1
generally shows redundant occupancy of proximal promoters with
GABPA but specific interactions with a coregulatory partner,
RUNX1, generally take place in more distally located regions
where ETS1 binds in a ‘‘unique’’ manner [4]. This study also
revealed a putative link between ‘‘unique’’ binding of ETS1 and
gene function with an association with T cell-specific genes being
observed but this link remained functionally untested. Further-
more, the sequence characteristics of the core ETS1 binding sites
differ between ‘‘unique’’ and ‘‘redundant’’ binding sites, as we
observed in this study for ELK1. Thus, there are clear similarities
in how ETS transcription factors generate specificity in their
mechanism of action and biological functions. However, despite
these underlying similarities, our study clearly demonstrates that
ELK1 and ETS1 function in a different manner. Furthermore, our
study was also able to make links to regulatory outcomes (see
below) at different classes of target genes which have not yet been
established for ETS1.
Importantly, the location of the ELK1 binding sites in proximal
promoter (defined as +/22 kb from the TSS) versus distal regions
is not as effective at partitioning of the data. Indeed, the ‘‘unique’’
ELK1 binding sites in the proximal promoter regions share
characteristics such as the distribution of binding motifs, over-
represented functional categories of targets, and association of
common regulatory events, with ‘‘unique’’ ELK1 binding sites
located in the distal regions (data not shown). Thus, the
mechanistic, regulatory, and functional connections that we
observe are not due to binding site location and instead reflect
whether ELK1 is likely working in a ‘‘unique’’ manner. However,
when we partitioned the data according to a different definition of
proximal binding (ie 27k bt o+2 kb from the TSS), we could
readily detect SRF and AP1 motifs in the distal regions but ETS
motifs were less obvious; the reciprocal was true in promoter-
proximal regions (data not shown). Moreover, there were
significantly more overlaps between distal ELK1 binding motifs
with FOS ChIP-seq data [19] (58/229) than with promoter-
proximal regions (20/300) (P-value,1610
26). This might reflect a
more combinatorial mode of action of ELK1 when it is associated
with distal binding regions.
Once the two types of ELK1 binding mode had been
established, we were then able to correlate binding with regulatory
outcomes. ‘‘Uniquely’’ bound regions are generally associated with
genes where ELK1 functions in an activating capacity, whereas
the converse is true of ‘‘redundantly’’ bound regions. Direct ELK1
target genes which are upregulated by EGF treatment are
generally associated with ‘‘unique’’ ELK1 binding regions,
consistent with a role for ELK1 as an EGF-responsive transcrip-
tional activator. Strikingly, the majority of ELK1 target genes were
barely affected by EGF treatment, despite the fact that ELK1 plays
a regulatory role at a large proportion of these. Thus although
ELK1 is generally thought to function by acting as a direct
recipient of ERK pathway signaling, this appears to be the
exception rather than the rule when considering its broader
cellular function (reviewed in [7–8,24]). It should, however, be
emphasised that even in the absence of EGF, basal ERK
activation is present in MCF10A cells (Figure 1C) and thus we
cannot rule out a role for constitutive low level signaling working
through ELK1 to its target genes.
The lack of EGF response is particularly prominent among the
‘‘redundantly’’ bound ELK1 target genes. In these cases it appears
likely that other ETS transcription factors such as GABPA can
substitute for ELK1 binding, and the function of ELK1 is to
compete for DNA occupancy with those ETS transcription factors.
Indeed, depletion of ELK1 or GABPA has a reciprocal effect on
the expression of ‘‘redundantly’’ bound target genes, suggesting
that a dynamic equilibrium between these transcription factors
exists in the cell to maintain target gene expression at the correct
level. In this scenario, ELK1 would either be repressive in nature
and GABPA activating, or alternatively, both might activate but
with GABPA activating to a higher level than ELK1. Similar
effects could occur amongst different family members as has been
suggested previously, at least at the level of DNA binding [3].
Importantly, our data also suggest that while redundancy at the
level of binding is observed, this binding might not translate into
functional redundancy.
Given the different binding modes identified for ELK1 and their
correlation with different regulatory outcomes for the associated
target genes, we then wished to examine whether this translated
into specific phenotypic responses. Unexpectedly, we uncovered a
clear distinction between the type of ELK1 binding mode
employed and the categories of target genes regulated. The
‘‘unique’’ ELK1 binding regions were closely associated with genes
encoding proteins involved in the actin cytoskeleton and related
processes, whereas the ‘‘redundantly’’ bound regions were
generally associated with genes encoding proteins controlling
aspects of gene expression. The latter observation suggests a
general role for ETS proteins in maintaining the levels of genes
encoding the gene expression machinery at the correct levels. A
similar conclusion was reached based on overlapping binding of
different ETS-proteins in a ChIP-chip study, where commonly
bound target genes were often designated as ‘‘housekeeping’’ [3].
However, our results suggested a unique non-redundant function
for ELK1 in controlling the expression of proteins associated with
the actin cytoskeleton and we subsequently demonstrated that this
was indeed the case. Upon ELK1 depletion, cytoskeletal defects
were observed and these led to defects in cell migration. A
previous study provided hints at such a connection with MMP9
identified as an ELK1 target gene relevant to cell migration [27].
However, a direct link was not made between ELK1 and cell
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for ELK1 in our study.
Interestingly, SRF has also been associated with controlling the
actin cytoskeleton and cell migration [22,23] but the role of ELK1
as a potential partner protein in that process has not been
addressed. Indeed, it is thought that the alternative SRF partner
protein MAL/MRTF plays the major role in this process
(reviewed in [28]). More recently, two different types of SRF
binding sites have been shown to control cytoskeletal gene
expression, where SRF binds either together or independently
with the ETS transcription factor PU.1 and these binding events
correlate with activation through ubiquitous promoter- and cell
type-specific enhancer driven mechanisms, respectively [29].
Thus, different SRF binding modes are associated with the same
biological process and type of regulation, while here we reveal that
ELK1 binding modes dictate different downstream outcomes.
Many of the target genes that are directly regulated by ELK1
differ from the SRF-regulated genes encoding proteins associated
with the actin cytoskeleton. Indeed, of the 57 genes in the actin/
migration network associated with ELK1 binding, only 14 were
previously shown to be direct SRF targets in HeLa cells [5]. This
suggests that these two transcription factors may control the
expression of different components of the network rather than
acting in a more general coordinated fashion. Indeed, we have
shown that only a subset of the ELK1 target genes which rely on
ELK1 for their expression, are also positively regulated by SRF.
One of these, ACTB, encodes b-actin, and is a well established
SRF target gene [e.g. 22, 23]. Importantly, we have confirmed the
role of ELK1 in controlling cell migration in several human breast-
derived epithelial cell lines, and it is possible that ELK1 may play a
role in cellular metastasis in the context of breast cancer. The
other major categories of ELK1-regulated target genes are
associated with cell survival and apoptosis. However both
‘‘uniquely’’ and ‘‘redundantly’’ bound target genes appear to be
involved. This association was expected due to the original
observation that ELK1 is required for the survival of MCF10A
cells [15].
In summary, this study has identified an intriguing link between
different modes of transcription factor binding and the control of
different functional categories of target genes. This permits a
specific phenotypic response to be achieved depending on the
intrinsic properties and the co-regulatory activities occurring at
different transcription factor binding sites. In the case of ELK1, we
uncover a specific role in controlling genes associated with the
actin cytoskeleton and also determine that it has a second function
in which it acts in a dynamic fashion with other ETS transcription
factors to maintain the correct expression of components of the
gene expression machinery. Future studies will attempt to uncover
the mechanistic differences utilized by ELK1 in the different
regulatory scenarios.
Materials and Methods
Tissue culture, RNA interference, and RT–PCR
MCF10A cells were maintained in DMEM/F12 containing 5%
horse serum, 20 ng/ml EGF, 10 mg/ml insulin, 100 ng/ml
cholera toxin and 0.5 mg/ml hydrocortisone. MDA-MB-231 cells
were grown in DMEM containing 10% FBS.
For RNAi, MCF10A and MDA-MB-231 cells were plated out
into a mixture of 83% growth medium, 17% OptiMEM
(Invitrogen), 20 nM siRNA and 0.33% Lipofectamine2000
(Invitrogen) followed by replacement of the transfection mix with
appropriate growth media after 12 hours. All siRNA constructs
were ON-TARGETplus SMART pools from Dharmacon except
for ELK1, where a custom-designed siRNA duplex corresponding
to the sequence GGCAATGGCCACATCATCT was used, and
for GABPA where additional duplexes were used from Santa-
Cruz. For experiments involving the culture of siRNA-transfected
cells longer than 64 hours, siRNA transfections were repeated at
t=48 hrs. For SRF knockdown followed by RT-PCR analysis,
two repeats were done with an ON-TARGETplus SMART pool
(Dharmacon) and one was performed with an alternative siRNA
duplex (Santa Cruz).
Real time RT-PCR was carried out as described previously
[30]. The primer pairs used for RT-PCR experiments are listed in
Table S5.
Expression microarray analysis
MCF10A cells were seeded into 6-well plates (520,000/well),
transfected with siELK1 or siGAPDH (control) and maintained in
media depleted of EGF for 48 hours. Cells were then stimulated
with complete media containing EGF for 30 minutes (with non-
stimulated populations used as control). Three biological replicates
were performed for each condition. RNA was isolated using the
RNeasy kit (QIAgene) according to the manufacturer’s protocol
and quantifiied with a Nanodrop ND-1000 spectrophotometer
(Nanodrop Technologies). Sample labeling and hybridization to
Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays were
performed according to manufacturer’s instructions.
Upon collection of signal, technical quality control was
performed with dChip (V2005) [31] using default settings.
Background correction, quantile normalization, and gene expres-
sion analysis were performed using RMA in Bioconductor [32].
Principal component analysis (PCA) was performed with Partek
Genomics Solution (version 6.5, Copyright 2010, Partek Inc., St.
Charles, MO, USA). Differential expression analysis between
samples was performed using Limma with the functions lmFit and
eBayes [33]. A two-factor ANOVA model was used with batch
pairing, since batch pairing was evident in the PCA analysis. Gene
lists of differentially expressed genes were controlled for false
discovery rate (FDR) errors using the method of QVALUE. All
probesets with signals lower than or equal to the background level
in the EGF treated control samples were discarded. For fold
changes of signal between any two conditions, only probesets with
Q values lower than 0.1 and P values lower than 0.05 were
retained. For probesets complementary to multiple HUGO official
gene symbols, only one gene name was retained. Probesets
associated with gene names showing changes of signal in opposite
directions were excluded from further analysis and if multiple
probesets were associated with one official gene symbol, only the
probeset exhibiting the largest change of expression was retained
for further analysis. The microarray expression data have been
submitted to array express (accession number E-MEXP-3407).
For clustering, signal intensities assigned to each probeset were
log10-transformed and z-scores were calculated [34]. These
transformed signal intensities were subsequently clustered in
MultiExperimentViewer (MeV) [35] using the k-means algorithm
with a preset of 8 clusters. These were subsequently organised
using the hierarchical clustering algorithm.
Wound healing, cell tracking assays, and
immunofluorescent staining
Cells seeded in duplicate into 12-well plates were transfected
with appropriate types of siRNA in media depleted of EGF
(MCF10A cells) or FBS (MDA-MB-231 cells). After 48 hours
wounds were created in each well using sterile pipette tips; wounds
were scanned visually to ensure similar width. Cells were washed
twice with 16 PBS and media containing either 20 ng/ml EGF
DNA Binding Modes Determine Transcription Programs
PLoS Genetics | www.plosgenetics.org 11 May 2012 | Volume 8 | Issue 5 | e1002694(MCF10A cells) or 10% FBS (MDA-MB-231 cells) was added. For
MDA-MB-231 cells, after 18 hours cells were stained with crystal
violet. Four images were taken for each of the tested conditions,
the area unoccupied by cells in each image was measured. Average
values for each biological repeat were normalised to control
(siGAPDH transfection). For MCF10A cells, upon stimulation
plates were transferred to a chamber heated to 37uC and aerated
with 5% CO2 and imaged for 15 hours. The area unoccupied by
cells was measured at one hour intervals and normalised to values
specific for the siGAPDH-transfected control. Alternatively, after
15 hours cells were fixed and stained with crystal violet. For single
cell tracking, sparsely seeded cultured of MCF10A cells were
treated identically as in wound healing assays (without the
formation of wounds). All images were processed and analysed
using ImageJ and Adobe Photoshop CS2.
Fixed cells were visualised using a Leica DMIL upright
microscope coupled with a diagnostic instruments HRP045-NIK
camera and a 20x/0.30 CPlan Ph1 – air objective. Images were
acquired through the SPOT Basic software (Diagnostic Instru-
ments) and processed in ImageJ and Adobe Photoshop CS2. Live
cells were imaged in a heated, CO2-enriched chamber of a Leica
DM IRE microscope equipped with motorised XYZ stages
(Mauhauser) and a 20x/0.50 HC PlanFluotar (Ph2) objective.
Images were acquired with a Coolsnap HQ CCD camera
(Photometrics) through the Image Pro 6.3 software (Media
Cybernetics LtD) and later processed using ImageJ.
For immunofluoresence experiments, cells were fixed with 3.7%
paraformaldehyde in 16PBS, permeabilised with 0.01% Triton
X-100 in 16PBS, washed twice with 16PBS, stained for 20 min
with a solution of AlexaFluor488 phalloidin (Invitrogen), then
washed three times with PBS. For detecting DNA, cells were co-
stained with a 1 mg/ml solution of the Hoechst dye. Cells were
imaged using Olympus BX51 upright microscopes equipped with
20x/0.50 UPlanFln – air objectives and captured with a Coolsnap
HQ camera through MetaVue Software (Molecular Devices).
Western blot analysis
Western blotting was carried out with the primary antibodies;
ELK1 (Epitomics, #1277-1), cFOS (SantaCruz, sc7202), ERK2
(SantaCruz, sc154), and phospho-ERK (Cell Signalling, 9106S).
The proteins were detected either by chemiluminescence with
SuperSignal West Dura Substrate (Pierce) and visualised with a
Fluor-S MultiImager (Bio-Rad) or for infrared dye-conjugated
antibodies, signal was collected with a Li-cor Odyssey Infrared
Imager.
Chromatin immunoprecipitation (ChIP) assays
ChIP assays using control IgG (Millipore) or antibodies specific
to ELK1 (Epitomics) or cFOS (Santa Cruz) were performed
essentially as described previously (O’Donnell et al. 2008) using
3610
6 MCF10A cells for a standard ChIP and 5.4610
7 cells for a
ChIP-seq experiment, grown in media depleted for EGF for 48 hrs
for ELK1 ChIP or following stimulation with EGF re-addition for
2 hours for FOS. Bound promoters were detected by quantitative
PCR using primers listed in Table S5. Quantitative PCR was
performed at least in duplicate, from at least three independent
experiments, and analysed as described previously [5].
ChIP–seq assays
Samples for ChIP-seq were prepared as described above and
libraries were generated and sequencing was performed on a Life
Technologies SOLiD 3.5 System (Applied Biosystems) according
to the manufacturer’s protocols. Two repeats were performed.
SOLiD (Applied Biosystems) *.csfasta sequencer reads were
truncated to 32 nt using a perl script: SOLiD_preprocess_filter_v1.pl,
available at http://hts.rutgers.edu/filter/. Reads were then
aligned to build 18 of human genome from March 2006 (hereafter
referred to as hg18) using Corona-Lite 4.2.2 (Life Technologies)
and allowing from 0 to 3 mismatches. Aligned reads were used for
identification of peaks by MACS v. 1.3.7.1 [36]. For each of the
two repeats, the ELK1 signal was compared sequentially to the
IgG and input signals and the overlaps of the resulting sets of
regions were carried out using Galaxy [37,38]. The resulting sets
of ELK1-specific peaks for each repeat experiment were once
more overlapped and a high confidence dataset was defined as
regions identified in repeat 2 that overlapped those identified in
repeat 1. Regions identified only in repeat 2 are considered to be
low-confidence targets. In both cases, only regions characterised
by a False Discovery Rate (FDR) lower than 10% were retained.
The ChIP-seq data have been submitted to array express
(accession number E-MTAB-830).
For association of ELK1 binding regions with potential
regulated genes, each ChIP-seq region was assigned to its nearest
gene annotated in the refGene table (release 41, May 2010) of the
RefSeq Genes track, downloaded from the UCSC Table
Browser. This was based on the position of summit of each peak
(identified by MACS) and the position of the TSS of the relevant
RefSeq gene. Overlaps between ChIP-seq-associated genes and
microarray-generated gene expression data were determined
using an online tool (http://jura.wi.mit.edu/bioc/tools/compare.
php).
Bioinformatics analysis
The genomic distribution of peaks was determined using CEAS
[39]. De novo motif discovery was carried out using Weeder v. 1.4.2
[40]. The resulting top scoring position weight matrices (PWMs)
were parsed against known transcription factor PWMs from the
JASPAR 2010 database [41] using STAMP [42].
Word-based motif searches were performed using two PERL
scripts: CountRegexGFF_IUPAC_1input_nosummary.pl (identifies num-
ber of occurrences of a particular IUPAC string on one or both
strands of one or more sequences provided in FASTA format) and
CountRegexGFF_IUPAC_1input_simple_output.pl (returns positions of
all occurrences of a given IUPAC string within given FASTA
sequences).
For constructing networks, lists of gene names assigned to ChIP-
seq regions were uploaded into STRING [43]. The resulting
networks were saved as *.txt files and then uploaded into
Cytoscape (v. 2.7.0) with cumulative scores of coexpression,
textmining, knowledge and experimental data as proximity
criteria. yFilesRorganic network layouts were applied and the
positioning and graphic representation of nodes were adjusted
manually for increased clarity.
For functional profiling of ELK1 binding regions identified
by ChIP-seq, Gene Ontology was performed using GREAT v.
1.2.6 [18] with the default (basal plus extension) gene
regulatory definition option. Here, each ChIP-seq region is
assigned to all genes whose domains it overlaps. Significance
was determined by FDR,0.05, and terms significant by both
the region-based binomial test and gene name-based hyper-
geometric test are reported. Gene Ontology analysis of lists of
gene names was performed using DAVID v. 6.7 [21] and terms
with P-values,0.05 were retained. In each case, Official Gene
Symbol was used. Gene Ontology of networks was carried out
using the Cytoscape plugin BiNGO (v. 2.42) [44] with default
settings.
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Statistical analysis for qRT-PCR studies and ChIP assays were
performed using paired, 2-tailed Student’s t test. The error bars in
all graphs represent standard deviation. Fisher’s Exact tests and
Chi-square tests were used to compare two different distributions
of pairs of datasets with respect to a particular condition. Z-score
analysis of overlaps between two gene name lists was performed
using a PERL script using 10000 background lists of Official Gene
Names of size of one of the comparator datasets. Average overlap
with standard deviation was recorded and z-score was calculated
as the ratio of difference between actual overlap and this average
overlap over the standard deviation. Kolomogorov-Smirnov tests
were used to determine the statistical significance of differences in
shape and range between two distributions. The Genomic
HyperBrowser was used to determine the statistical significance
of overlaps of sets DNA regions with the following settings: regions
of dataset 1 fixed, region sizes and number of dataset 2 fixed,
tested hypothesis: overlaps more than expected, overlap tested for
the whole genome, with each chromosome treated as a separate
bin (maximum possible bin size).
Data release
The ChIP-seq and microarray expression data have been
submitted to array express (accession numbers E-MTAB-830 and
E-MEXP-3407) and the data will be released upon publication.
Supporting Information
Figure S1 Summary of microarray analysis of gene expression
changes in either siGAPDH or siELK1-treated cells upon EGF
stimulation. The numbers of genes which become up- or down-
regulated upon EGF stimulation are indicated.
(PDF)
Figure S2 Validation of ChIP-seq datasets. qPCR validation of
a range of ELK1 binding regions identified by ChIP-seq. Binding
regions were ordered by descending tag count and candidates
were selected by taking binding regions approximately every
fiftieth and every one-hundredth position in the lists from the high
and lower confidence ELK1 ChIP-seq datasets. ChIP-seq peak
profiles for the ELK1 (blue vertical line) and IgG (yellow vertical
line) samples are shown on the left. Bars in profile windows
indicate 500 nt; RefSeq annotated genes are shown (if present) and
the TSS is indicated by an arrow. The signal range (y-axis) is 0 to
100 for all regions apart from region 2 in the high confidence
dataset (WNK1), where the maximum reaches 225. Specific
binding of ELK1 to each region was validated in ChIP-qPCR
experiments carried out in three biological repeats (shown on the
right of the corresponding peak profiles); bars show the average
percentages of input precipitated with the ELK1 antibody (blue
bars) or non-specific IgG (yellow bars) with standard deviations.
Titles of the graphs indicate the position of each region on a list
ordered with descending tag count of ELK1 signal (prefix ‘‘L’’
denotes position on lower confidence list) and the name of the
nearest annotated RefSeq gene. Binding regions from the lower
confidence dataset are boxed. ABLIM2, CPLX1 and intron 3 of the
SRF gene (SRFint3) are negative controls and EGR2 is a positive
control. Data are summarized in Figure 2A.
(PDF)
Figure S3 Role of ELK1 in MDA-MB-231 cells. (A) ChIP-
qPCR experiments were carried out in MDA-MB-231 cells for
regions bound by ELK1 in MCF10A cells (see Figure 2A, and
Figure S2; only the high confidence dataset was tested). Bars show
the average percentages of input precipitated with the ELK1
antibody (black bars) or non-specific IgG (grey bars) with standard
deviations. Numbers above bars show fold enrichment of ELK1
signal over IgG. EGR2 – positive control, ABLIM2, CPLX1,
SRFint3 – negative controls. (B) The effect of depletion of ELK1 on
mRNA levels of the indicated actin cytoskeleton- and migration-
associated genes. RT-qPCR analysis of the mRNA levels of the
indicated genes was carried out in serum starved MDA-MB-231
cells transfected with siELK1, with normalisation to an siGAPDH-
transfected control; bars show average values from three biological
repeats with standard deviations. Levels of ELK1 mRNA indicate
the efficiency of depletion and RBL2 and EFR3A are control genes
not associated with ELK1 Binding regions; * P,0.05, ** P,0.01
(Student’s paired t-test). (C) Representative images of wounds
created in monolayers of siGAPDH- or siELK1-transfected MDA-
MB-231 cells, 18 hours post-stimulation with media containing
10% FBS. Lines show borders of areas which were used for
quantification. (D) Areas of wounds in MDA-MB-231 cells treated
as in (C) were measured in duplicates and normalised to control
(siGAPDH). Bars show the average of three biological repeats with
standard deviation. P-value was obtained from a two-tailed paired
Student’s t-test. (E) Numbers of MDA-MB-231 cells in a siELK1-
transfected population were counted at 48 and 96 hours post-
initial transfection and normalised to control (siGAPDH). Bars
show average values of three biological repeats (performed in
duplicates) with standard deviations. * P,0.05 (Student’s paired t-
test).
(PDF)
Figure S4 Overlaps between ELK1 binding regions in MCF10A
cells and HeLa cells. (A) Overlap between regions identified by
ChIP-seq as bound by ELK1 in MCF10A cells, and by ChIP-chip
as bound by ELK1 in HeLa cells [5]. (B) Overlap between regions
identified by ChIP-seq as bound by ELK1 in MCF10A cells, and
by ChIP-seq as bound by ELK1 in HeLa cells [17]. The ChIP-seq
data from MCF10A cells is partitioned into promoter proximal
(210 kb to +2.5 kb from the TSS) and distal binding regions to
enable comparison with the ChIP-chip data which only samples
this region of the genome.
(PDF)
Figure S5 Gene Ontology analysis of regions bound by ELK1.
GREAT Gene Ontology analysis was carried out for all regions
from the high confidence dataset using default settings. Signifi-
cantly enriched categories are shown. Categories associated with
the actin cytoskeleton and migration are indicated by arrows.
(PDF)
Figure S6 Depletion of ELK1 changes the expression of distinct
functional categories of genes. (A) DAVID functional clustering
analysis was carried out for genes assigned to ELK1 ChIP-seq
regions which show a significant change in expression levels in
MCF10A cells depleted of ELK1 (as compared to an siGAPDH-
transfected control), at either time point of EGF stimulation.
Functional assignments of the top ten clusters are shown. GO
terms were classified as gene expression-related (grey), actin
cytoskeleton/migration-related (green) and cell survival related
(orange). (B) DAVID functional clustering results for genes
upregulated upon ELK1 depletion; the top five clusters are
shown. (C) As in (B), but for downregulated genes.
(PDF)
Figure S7 Overlaps between ELK1 binding regions and binding
of other transcription factors; FOS/AP1 binding associates with
‘‘unique’’ ELK1-bound regions. (A) Overlap between regions
identified by ChIP-seq as bound by ELK1 (MCF10A cells) and
ELK4 (HeLa cells) [17]. (B) Overlap between regions identified by
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ETS transcription factors [2,17,24]. RPWE1 are normal prostate,
Jurkat are T cell lymphoma, VCaP are prostate cancer, HL60 are
leukaemia and HeLa are cervical cancer cells. The data are
compared to the 303 ‘‘unique’’ and 226 ‘‘redundant’’ ELK1
binding regions, and the % overlap is presented (relative to the
number of ELK1 regions). P-values are calculated in Chi square
tests and significance values assigned to datasets which show a
preferential differential enrichment with the ‘‘redundant’’ ELK1
binding regions. (C) Overlap between regions identified by ChIP-
seq as bound by ELK1 (MCF10A cells), SRF (Jurkat cells; [19])
and GABPA (Jurkat cells; [19]). (D) Occurrence of FOS/AP1
motifs corresponding to the TGANTCA consensus (purple
quadrants) in ‘‘unique’’ and ‘‘redundant’’ ELK1-bound regions.
P-values were calculated using a Chi square test. (E) Western blot
showing expression levels of FOS in MCF10A cells at indicated
times after EGF addition. (F) Binding of FOS to ‘‘unique’’ (WNK1,
ITGAV, PAPLN) and ‘‘redundant’’ (CAP1) regions was determined
in MCF10A cells two hours post-EGF stimulation in ChIP-qPCR
assays. Numbers above bars indicate fold enrichment of FOS
signal over IgG. KLF9 – positive control.
(PDF)
Figure S8 Comparison of ELK1 binding motifs found in vivo and
in vitro. TFBS logos obtained through STAMP-assisted visualisa-
tion of Weeder-derived position weight matrices of motifs
overrepresented in ‘‘unique’’ and ‘‘redundant’’ ELK1-bound
regions from the ChIP-seq experiment in MCF10A cells (see
Figure 3C). For comparison, the logo for the ELK1 binding site
obtained from an in vitro site-selection study [2] is shown at the
bottom.
(PDF)
Figure S9 ‘‘Unique’’ and ‘‘redundant’’ ELK1-bound regions
regulate distinct sets of target genes. Summary profiles of the target
genes in clusters 1, 3, 5 and 6 (see Figure 4A). The data are
presented as changes of the individual (grey) and average (black)
expression values of genes in each cluster under each of the four
experimental conditions. For each gene, the mean of the signals
across all four conditions was set as zero, and expression levels (z-
transformed) are presented relative to this value.
(PDF)
Figure S10 The role of ELK1, GABPA and SRF in regulating
‘‘unique’’ ELK1 target genes. (A–C) mRNA levels of nine actin
cytoskeleton- and migration-associated genes were measured by
RT-qPCR from MCF10A cells grown in the absence of EGF (B
and C) or additionally treated with EGF for 30 mins (A) and
transfected with siRNAs against ELK1 (A), GABPA (B) or SRF
(C); these were then normalised to an siGAPDH-transfected
control (taken as 1). Bars show average values from two to three
biological repeats with standard deviations. Levels of ELK1,
GABPA and SRF mRNAs indicate the efficiency of depletion;
RBL2, EFR3A are negative controls which do not associate with
ELK1. Significantly altered expression is depicted with orange
bars; * P,0.05, ** P,0.01 (Student’s paired t-test).
(PDF)
Figure S11 ELK1 controls a network of actin/migration-related
genes. Network formed by proteins encoded by actin cytoskeleton/
migration-related genes associated with ‘‘unique’’ ELK1-bound
regions (each protein denoted by a circle). Asterisks mark genes
tested in Figure S10 and Figure 5A (PFN1 is associated with a
redundant region). Pink circles indicate that gene expression is
changed upon ELK1 depletion. Circles to the right of the figure
show ELK1 target genes attributed to these functional terms but
which do not have catalogued connections to the other genes in
the network.
(PDF)
Figure S12 ELK1 controls a network of survival-related genes.
Networks formed by proteins encoded by survival-related genes
associated with ‘‘unique’’ or ‘‘redundant’’ ELK1-bound regions
(each protein denoted by a circle). Asterisks mark genes tested in
Figure 5A and Figure S10, Pink and green circles indicate that the
genes are associated with ‘‘unique’’ ELK1 binding regions and
their gene expression is changed or unchanged respectively upon
ELK1 depletion. Yellow and blue circles indicate that the genes
are associated with ‘‘redundant’’ ELK1 binding regions and their
gene expression is changed or unchanged respectively upon ELK1
depletion. Circles to the right of the figure show ELK1 target
genes attributed to these functional terms but which do not have
catalogued connections to the other genes in the network.
(PDF)
Figure S13 ELK1 controls a network of gene expression-related
genes. Networks formed by proteins encoded by gene expression-
related genes associated with ‘‘unique’’ (A) and ‘‘redundant’’ (B)
ELK1-bound regions. Asterisks mark genes tested in Figure S10,
Figure 5A. Pink and yellow circles indicate that the genes are
associated with ‘‘unique’’ and ‘‘redundant’’ ELK1 binding regions
and their gene expression is changed upon ELK1 depletion
whereas green and blue circles indicate that the genes are
associated with ‘‘unique’’ and ‘‘redundant’’ ELK1 binding regions
and their gene expression is unchanged upon ELK1 depletion.
Circles to the right of the figure show ELK1 target genes
attributed to these functional terms but which do not have
catalogued connections to the other genes in the network.
Subclusters of proteins that correspond to distinct categories of
regulators are boxed.
(PDF)
Figure S14 Depletion of ELK1 impairs MCF10A cell survival.
The numbers of MCF10A cells were determined 48 h and 96 h
post-initial treatement with ELK1 siRNA and normalised to
siGAPDH-transfected control. Cells were stimulated with EGF at
t=48 h (together with the second transfection). The experiment
was performed in duplicate; average values and standard
deviations from three biological repeats are shown. Significance
was determined in a Student’s paired t-test, * P,0.05.
(PDF)
Figure S15 ELK1-regulated genes control the actin cytoskeleton
and motility of MCF10A cells. (A) Depletion levels of each of the
indicated mRNA species following siRNA treatment were
determined in RT-qPCR reactions. Bars show average values
from three biological repeats with standard deviations, and are
shown relative to cells treated with siGAPDH (taken as 1). (B)
Representative images of MCF10A cells transfected with the
indicated siRNA species, starved for EGF for 48 h and
subsequently stimulated with EGF for 24 h and stained with
phalloidin (green) and the Hoechst dye (blue). (C) The percentage
of cells exhibiting membrane protrusions was calculated for each
of the indicated siRNA transfections, as well as for siGAPDH
(negative) and siELK1 (positive) – transfected controls. Bars show
average values from three biological repeats with standard
deviations; three fields were scored for each repeat. (D)
Representative images of wounds created in monolayers of
MCF10A cells transfected with the indicated siRNAs, are shown
15 hours post-stimulation with EGF (cells were stained with crystal
violet). (E) Areas of wounds in MCF10A cells treated as in (D) were
measured in duplicates and normalised to control (siGAPDH).
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deviations. P-values were calculated in Student’s paired t-tests, *
P,0.05
(PDF)
Figure S16 Depletion of ELK1 target genes impairs MCF10A
cell migration. Migratory trajectories of MCF10A cells transfected
with the indicated mRNA species, manually tracked between
t=1 h and t=7 h of EGF stimulation. Each coloured line
represents the path travelled by an individual cell.
(PDF)
Table S1 Microarray analysis of gene expression changes upon
EGF treatment and/or depletion of ELK1 in MCF10A cells. Data
are shown for (A) all the genes which show significant changes in
expression upon EGF treatment and/or depletion of ELK1 and
(B) genes which show significant changes in expression upon EGF
treatment and/or depletion of ELK1 and are also associated with
ELK1 binding regions. Only probesets with Q values lower than
0.1 and P values lower than 0.05 were retained, and only one
probeset per gene was considered, see Materials and Methods for
details.
(XLSX)
Table S2 ChIP-seq analysis of ELK1 binding regions in
MCF10A cells. Data are shown for (A) high confidence binding
regions which have a FDR,10% and appear in two independent
experiments and (B) lower confidence binding regions which have
a FDR,10% but appear in only one experiment. Genomic
coordinates, summits, tag numbers and significance values are
shown for each region from the experiment (repeat 2) which gave
peaks with more stringent P-values.
(XLSX)
Table S3 Z-transformed mRNA expression data for clustering
analysis. The mRNA expression changes for genes associated with
ELK1-bound regions that show a significant response to siELK1
and/or EGF treatment are shown as z-transformed data for each
of four different experimental conditions, i.e. plus/minus siELK1
treatment, plus/minus EGF treatment for 30 mins. This data was
used for generating the k-means clustering of expression levels
shown in Figure 4A.
(XLSX)
Table S4 ‘‘Unique’’ and ‘‘redundant’’ ELK1-bound genes
associate with distinct sets of GO terms. DAVID Gene Ontology
was performed on lists of genes associated with ‘‘unique’’ or
‘‘redundant’’ ELK1-bound regions that changed expression upon
depletion of ELK1. Lists were sorted with ascending P-values of
individual terms. These data are shown as a heatmap in Figure 4G.
(XLSX)
Table S5 List of PCR primers used in (A) ChIP and (B) RT-
PCR experiments. Nucleotide sequences are given in both cases,
and the chromosomal locations of the primers used for ChIP
(according to the hg18 genome assembly).
(PDF)
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